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To elucidate the cellular tropism of Moloney murine leukemia virus (MuLV), we have studied the transduction efficiency
of a recombinant MuLV vector carrying the b-galactosidase reporter gene on a variety of rodent cells. Under optimal
conditions for in vitro cell transduction, primary cultures of adult rat fibroblasts derived from various organs were very
poorly transduced by the ecotropic MuLV vector (0.02–0.12%) when compared to immortalized cells such as the F2408
(42%) and 3Y1 (defined as 100%) lines. Primary cultures of fibroblasts from neonatal (3.7%) or embryonic rat tissues (4.6%)
and primary cultures of rat mammary epithelial cells (3–4%) were somewhat more susceptible. Immortalization of rodent
fibroblasts with Polyomavirus Large T, SV40 Large T, and E6-E7 genes of human papilloma virus resulted in a modest or
minimal increase in transduction efficiency, and introduction of the transforming genes v-Src, v-Ras, and v-Raf was in most
instances associated with a decrease in MuLV vector entry. Variability of transduction efficiency was not related to differ-
ences in cellular growth rate and treatment of MuLV vectors in vitro with deoxyribonucleoside triphosphates and treatment
of cells in culture with protease inhibitors failed to modify cellular entry of the MuLV vector. On the other hand, inhibition
of cellular glycosylation with swansonine, 1-deoxymannojirimycin and, primarily, tunicamycin enhanced entry of the ecotropic
vector by up to 220-fold, particularly into cells which were otherwise highly resistant. These findings demonstrate major
differences in transduction efficiency of the ecotropic MuLV vector on rodent cells and indicate that cellular glycosylation
plays a critical role in determining MuLV cellular tropism. q 1997 Academic Press
INTRODUCTION gibbon ape leukemia virus receptor family (Miller et al.,
1994; van Zeijl et al., 1994) and is involved in phosphate
Murine leukemia retroviruses (MuLVs) are divided into transport (Kavanaugh et al., 1994; Kozak et al., 1995).
five categories according to their host range infectivity Although in any given subgroup, MuLVs are thought to
and interference characteristics (Rein and Schultz, 1984). be able to infect all cell types of a permissive species,
The ecotropic subgroup can infect rodent cells but not these new findings raise the possibility that expression
human cells, whereas the amphotropic subgroup can level and/or proper structural conformation of MuLV re-
infect a variety of cell types, including rodent and primate ceptor on the plasma membrane of the host cell may
cells. Retrovirus infection involves multiple processes, ultimately determine cell vulnerability to viral infection.
including virion binding to a specific plasma membrane Cellular tropism of MuLV is poorly understood and
receptor, intracellular translocation, reverse transcription we have previously found that primary cultures of rat
of its genomic RNA into proviral DNA, and integration of fibroblasts are very poorly transduced by oncogene-car-
the latter into the host cell genome. Binding to the plasma rying MuLV retroviral vectors when compared to estab-
membrane receptor is a key event which determines lished rodent lines (Tavoloni and Inoue, 1977). Clarifying
virus host range infectivity and, for MuLV, this interaction the cellular tropism of MuLV is important not only for
is mediated by the viral envelope glycoprotein gp70 (De understanding virus–cell interaction and pathogenesis
Larco and Todaro, 1976; Marsh and Helenius, 1989). The but also for establishing the usefulness of MuLV vectors
gp70 of the ecotropic subgroup of MuLV binds to the as gene delivery vehicles. Accordingly, the present stud-
MCAT-1 receptor (Albritton et al., 1989), which functions ies were carried out to examine the ability of a recombi-
as a cationic amino acid transporter (Kim et al., 1991; nant MuLV ecotropic vector to transduce various types
Wang et al., 1991). The gp70 of the amphotropic subgroup of rodent cells in culture and to clarify the mechanism
utilizes the GLVR-2 receptor, recently designated PiT2 underlying the observed differences in transduction effi-
(Eiden et al., 1996), which is a second member of the ciency.
METHODS
1 To whom correspondence and reprint requests should be ad- MuLV vector production
dressed at Mount Sinai Medical Center, Box 1039, One Gustave L
In these studies, we have used a recombinant MuLVLevy Place, New York, NY 10029-6574. Fax: (212) 348-3517. E-mail:
IN%‘‘Tavoloni@msvax.mssm.edu’’. virus (the terms virus and vector will be used inter-
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changeably) carrying the b-galactosidase (LacZ) re- Cell lines
porter gene (BAG). BAG DNA (Price et al., 1987) was
Two rat fibroblast lines, 3Y1 (Kimura et al., 1975) andtransfected into c2 cells by the calcium-phosphate pro-
F2408 (Freeman et al., 1973), both of which were derivedcedure as previously described (Tavoloni et al., 1994).
from REF and were spontaneously immortalized in cul-Under G418 selection (0.4 mg/ml active drug), a line
ture, and two mouse fibroblast lines, NIH 3T3 and 3T3-was established which produced a replication-defec-
L1 (Green and Kehinde, 1975), were included in thesetive BAG virus (BAGEV) with ecotropic host range. In
studies. Additional fibroblast lines were established inthe BAGEV producer line, 100% of the cells were posi-
our laboratory by introducing into primary cultures 3Y1,tive for b-galactosidase expression (X-Gal), thus indicat-
F2408, and 3T3-L1 cells immortalizing genes such asing that all functional BAGEV virions encoded both the
SV40 Large T (SV-LgT), Polyomavirus Large T (PyLT), andG418 resistance and the b-galactosidase genes. The vi-
E6-E7 of human papilloma virus (E6/E7), or transformingrus-containing supernatant was collected 36 hr after
genes such as v-Src, v-Ras, or v-Raf (Tavoloni and Inoue,the stock producer line reached confluence. The super-
1997). In addition, three lines of spontaneously immortal-natant was filtered through a 0.45-mm filter and stored
ized mammary epithelial cells of mouse origin [COMMA-in aliquots at 0707. Each infection experiment utilized a
D (Danielson et al., 1984), TM-3 (Ozbun et al., 1993), andfreshly thawed aliquot and remaining virus solution was
C-127 (Lowy et al., 1978)] and two lines of human originnever refrozen for further use. Helper virus, determined
[184B5 (Stampfer and Bartley, 1985); T-47D (Keydar et al.,by horizontal transmission and syncytium assay in XC
1979)] were included. Fibroblast and mammary epithelial
cells (Klement et al., 1969), was never present in all vector
lines were cultured as described for the respective pri-
preparations. Procedures for producing other retrovi-
mary cultures of these cells.
ruses carrying immortalizing or transforming genes were
similar and described previously (Tavoloni et al., 1994;
Infection protocolTavoloni and Inoue, 1997).
Cells (2 1 105/6-cm dish) were plated as single cell
suspension and 16 hrs later infected with 1 ml of cul-Preparation of primary cell cultures
ture medium containing a constant volume (usually 100
ml) of BAGEV virus stock solution and 4 mg/ml polybrene.Rodent cells were isolated from embryos, neonatal
Cells were exposed to the virus for 4 hr at 377 in a CO2rats, and mature rats. Embryo fibroblasts (REF) were pre-
incubator, after which 1 ml of fresh growth medium was
pared from surgically removed embryos at their 16th day
added to halve the polybrene concentration. Cells were
of gestation using trypsin (0.25%) digestion of minced
then maintained under standard culture conditions until
tissue after viscera, limbs, head, and organs within the
stained for X-Gal (48 hr later). Optimal conditions for cel-
thoracic cavity were removed (Tavoloni et al., 1994). Rat
lular transduction, including polybrene concentration,
neonatal fibroblasts (RNF) were prepared from newborn
cell density, pH (7.0–7.4) of culture medium, and time
animals (12 hr after birth) using similar procedures.
allowed for retroviral integration (48 hr) were estab-
Fibroblasts from mature rats were isolated from the lung
lished in preliminary experiments with highly permissive
(RLF) and dermis (RDF) of male rats of 50–75 days of (3Y1 line) and poorly permissive (primary cultures) cell
age also following trypsin digestion of these respective types. In each infection experiment, positive (3Y1 cells)
tissues. Rat mammary epithelial cells (RMEC) were iso- and negative (mock infection) control dishes were in-
lated from the mammary glands of virgin females of 50 cluded. Unless otherwise indicated, infections of primary
days of age as described by Hahm and Ip (1990). Rat cultures were invariably conducted during the first 7 days
mammary fibroblasts (RMF) were separated during the of continuous growth in culture. The same infection pro-
isolation of RMEC. In general, rats were of the Sprague– tocol was adopted when recombinant viruses were used
Dawley strain (Charles River Laboratories, Wilmington, to introduce immortalizing or transforming genes into var-
MA), although mammary fibroblasts isolated from Fisher ious cell types (Tavoloni and Inoue, 1997).
344 rats were used in selective experiments. Unless oth-
erwise indicated, primary cultures of rat fibroblasts were Analytical procedures
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% fetal bovine serum (FBS), 100 U/ml peni- Functional titer of BAGEV virus was determined in 3Y1
cillin, 100 mg/ml streptomycin, and 250 ng/ml amphoteri- cells since this line was the most susceptible to infec-
cin B. Primary cultures of RMEC were grown in DMEM/ tion. Titer was determined by counting the number of X-
F12 (1:1) medium containing FBS (5%), insulin (10 mg/ml), Gal-positive cells 48 hr postinfection in limiting-dilution
hydrocortisone (1 mg/ ml), epidermal growth factor (15 infections, and it averaged 6 1 105 units/ml. Cell growth
ng/ml), cholera toxin (100 ng/ml), progesterone (1 mg/ml), rate was measured in duplicate dishes during the time
prolactin (1 mg/ml), gentamicin (25 mg/ml), amphotericin cells were exposed to the vector. Doubling times were
calculated during the exponential growth phase byB (250 ng/ml), and HEPES buffer (12 mM).
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counting either the number of trypsinized cells with a later by exposing cells to the vector dissolved in such
a conditioned medium.hemocytometer or the number of attached cells in three
to four small areas encircled with a marker under the
dish (Tavoloni et al., 1994). For X-Gal staining (Price et MATERIALS
al., 1987; Tavoloni, 1997), cells were washed once in
DMEM was purchased from Whittaker (Walkersville,cold phosphate-buffered saline (PBS) and fixed for 5 min
MD), F-12 from GIBCO (Gaithersburg, MD), and FBS fromat room temperature with a solution of 1% formalin– 0.2%
Harlan (Indianapolis, IN). dNTPs, restriction endonucle-glutaraldehyde in PBS. After three washes with PBS,
ases, and other reagents for DNA manipulation and plas-cells were exposed to 2 ml of a PBS solution containing
mid preparation were purchased from New England Bio-5 mM K3Fe[CN]6 , 5 mM K4Fe[CN]6r3H2O, 2 mM MgCl2 ,
labs (Boston, MA) and/or Qiagen (Chatsworth, CA). Leu-100 mM Tris (pH 7.4), and 1 mg/ml 5-bromo-4-chloro-3-
petin and aprotinin were from Calbiochem (San Diego,indolyl-b-galactopyranoside, and placed at 377 for 24 hr.
CA) whereas all other reagents were purchased fromX-Gal staining was scored as number of blue cells in
Sigma (St. Louis, MO) unless otherwise indicated.no less than 30 microscope fields of known area defined
by a grid in the eyepiece. When stained cells were very
RESULTSfew, the entire dish was inspected. X-Gal staining was
similarly performed in mock infected cells to determine BAGEV transduction efficiency on rodent cells
background contribution. With all cell types studied here,
no background staining was observed. To study the role As summarized in Table 1, major differences in BAGEV
transduction efficiencies were observed among variousof cellular glycosylation in transduction efficiency, tuni-
camycin (0 –1 mg/ml), 1-deoxymannojirimycin (0 –400 types of rodent cells. The immortal 3Y1 cells were the
most susceptible to BAGEV transduction, which was de-mg/ml), or swansonine (0 –40 mg/ml) were added to cul-
tures 24 hr prior to being infected by the virus. To deter- fined as 100%. Conversely, transduction of primary cul-
tures of fibroblasts isolated from various tissues of adultmine whether exposing the vector to deoxyribonucleo-
side triphosphates (dNTPs) prior to infection increased Sprague–Dawley rats was very poor and ranged from
0.12% to as low as 0.02% of that observed with 3Y1 cells.transduction efficiency (Zhang et al., 1993, 1995), BAGEV
solutions were incubated at 377 for 2 hr with 2.5 mM Mammary fibroblasts isolated from Fisher rats yielded
similar results. When fibroblasts were isolated from em-MgCl2 and 5 mM dATP, dTTP, dCTP, and dGTP prior to
being added to the target cells. The possible role of bryos or newborn animals, BAGEV transduction efficiency
was greater, yet it averaged only 4.6 and 3.7%, respec-cellular protease in affecting vector entry was examined
by treating cultures with various protease inhibitors, in- tively, of that observed with 3Y1 cells. Primary cultures of
RMEC were more susceptible than nonestablished fibro-cluding soybean trypsin inhibitor (SBTI), aprotinin, and
leupeptin at 0– 200 mg/ml, 0 – 300 kallikrein units/ml, and blasts isolated from the same rat, but again, immortalized
lines of rodent mammary cells were more efficiently trans-0 –100 mg/ml, respectively. For any given concentration,
protease inhibitors were added 24 hr before cells were duced than the primary cultures. Inefficient BAGEV entry
into primary cells was not secondary to suboptimal trans-exposed to the virus, readded with virus solution, and
added again 24 hr thereafter (24 hr before being ana- duction conditions. Changes in polybrene concentration,
pH of culture medium, density of target cells, and time oflyzed for X-Gal expression). In experiments designed to
study the relationship between cellular growth and vec- exposure to the virus resulted in no significant improve-
ment of MuLV vector entry into poorly permissive cells.tor entry, synchronization was induced with the following
protocol. Cells were seeded at 2.5 1 104/6-cm dish Similarly, inefficient virus penetration into primary cultures
was not improved by growth synchronization (Table 1),and cultured for 6 –12 hr (until fully attached) in growth
medium containing 10% FBS. The medium was then re- and no clear relationship was observed between cellular
growth rate and transduction efficiency. In fact, doublingmoved, and cells were washed with serum-free medium
and cultured for 48 hr in growth medium containing 0.5% times for the various cell types were similar to each other
and all were relatively short (Table 1). As expected, how-FBS. In experimental dishes, the medium was replaced
with one containing 10% FBS and cells were cultured ever, transduction efficiency was inversely related to the
age of primary cells in culture (Fig. 1). Senescing cellsfor an additional 12-hr period prior to infection. In control
dishes, cells were kept in 0.5% FBS throughout the infec- displayed longer doubling times and reduced susceptibil-
ity to BAGEV entry. Nevertheless, cellular immortalizationtion protocol. To test for the presence of a soluble se-
creted factor(s) which might inhibit vector entry (Miller per se was not a critical determinant of BAGEV penetra-
tion since immortalization of primary cells by the introduc-and Miller, 1993), the supernatant from cells that were
very poorly susceptible to BAGEV penetration was har- tion of PyLT, SV-LgT, and E6-E7 genes resulted in a vari-
able and, at times, minimal increase in transduction effi-vested, sterile filtered (0.45 mm), and added to another
cell type that was highly susceptible to transduction by ciency (Table 1). Similarly, no clear-cut relationship
between oncogenic transformation and MuLV vector en-such a vector. Infections were then performed 6– 24 hr
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TABLE 1
Transduction Efficiency of BAGEV Vector on Primary Cultures and Immortalized and Tumorigenic Lines of Rodent Cells
Relative
X-Gal-positive transduction Doubling
Cell type n cells/dish efficiency (%) time (hr)
Fibroblasts
Primary cultures
REF 4 1,844 { 512 4.6 17.8
RNF 4 1,506 { 416 3.7
RMF 7 46.4 { 7.8 0.1 20.5
RMFa 3 58.8 { 15.2 0.1
RMFb 3 92.6 { 18.5 0.2
RDF 6 24.6 { 11.1 0.1 22.1
RLF 6 18.6 { 4.7 0.1
Immortalized lines
3Y1 11 40,200 { 5732 100 14.3
F2408 3 16,692 { 3400 41.5 15.8
3T3 3 11,983 { 1648 29.8
3T3-L1 4 12,017 { 1692 29.9
RMFplt1c 3 431 { 258 1.1 17.6
RMFztv1c 4 1,309 { 213 3.3 17.9
RDFzev1c 3 184 { 32 0.5
Tumorigenic lines
RMFzsv1d 4 116 { 29 0.3 16.4
3Yzsv1d 3 155 { 21 0.4
3Yzrv1d 3 1,636 { 117 4.1
3Yzfv2d 4 6,021 { 1027 15.0
Mammary epithelial cells
Primary cultures
RMEC-1e 6 1,267 { 404 3.2 22.5
RMEC-2e 5 1,598 { 322 4.0
Immortalized lines
COMMA-D 4 6,355 { 1362 15.8
TM-3 4 4,856 { 1184 12.1 21.8
C127 4 16,463 { 2869 41.0
Tumorigenic lines
C127zsv1f 4 2,311 { 446 5.7
TMzrv1f 4 15,814 { 3417 39.3
Note. Values are means { SD (n indicates number of determinations). Relative transduction efficiency is expressed as a percentage of the
highest value observed in 3Y1 cells. For definitions of cell types, see Methods.
a Growth synchronized.
b Mammary fibroblasts isolated from Fisher 344 rats.
c These cells were immortalized by introducing PyLT (plt1), SV-LgT (ztv1), and E6-E7 (zev1) genes into primary cultures of rat mammary (RMF)
and dermal (RDF) fibroblasts.
d These cells were transformed by introducing v-Src (zsv1), v-Ras (zrv1), and v-Raf (zfv2) into rat mammary fibroblasts (RMF) and 3Y1 (3Y) cells.
e RMEC-1 and RMEC-2 indicate two different preparations of mammary epithelial cells obtained from separate female rats.
f These cells were transformed by introducing v-Src (zsv1) and v-Ras (zrv1) into the C127 and TM-3 lines, respectively.
try was found. As outlined in Table 1 for representative Miller, 1992, 1993; Talbot et al., 1995; Wilson and Eiden,
1991; Eiden et al., 1994). Because these results suggestexperiments, introduction of the transforming genes v-
Src, v-Ras, and v-Raf into primary cultures or immortalized that retroviral receptors may be nonfunctional when gly-
cosylated, we studied the effects of various inhibitors oflines failed to produce a consistent effect.
cellular glycosylation in the attempt to clarify the cause
of the variable transduction efficiency of BAGEV vectorRole of cellular glycosylation
observed in the present studies. As illustrated in Fig. 2
Previous studies have shown that inhibition of cellular and summarized in Table 2, treatment of rodent cell cul-
glycosylation allows entry of retroviruses into cells which tures with tunicamycin resulted in a major increase in
BAGEV transduction. In cells which were minimally sus-are otherwise partially or totally resistant (Miller and
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ceptible to virus entry, such as primary cultures of RMF
and a line of RDF immortalized by PyLT, up to a 220-fold
increase was observed following tunicamycin treatment
at optimal concentrations. Tunicamycin also enhanced
transduction of transformed cells, yet the decline associ-
ated with oncogene expression was not fully restored by
such a treatment. Increased cellular entry of BAGEV vec-
tor was induced by 1-deoxymannojirimycin and swan-
sonine as well, but the effects of these drugs were less
pronounced (Table 2). No beneficial effect was observed
when inhibitors of glycosylation were added to cultures
for 30 min (rather than 24 hr) prior to retrovirus transduc-
tion (Table 2), suggesting that enhanced vector entry was
not secondary to nonspecific effects of these drugs. In
addition, treatment with tunicamycin, 1-deoxymannojiri-
mycin, or swansonine did not allow transduction of hu-
man cells by the ecotropic vector (Table 2).
Other treatments and measurements
Although the above data indicate that cellular glycosyl-
ation plays an essential role in ecotropic MuLV vector
entry into mammalian cells, some of the observed differ-
ences in transduction efficiency were not entirely elimi-
nated by pharmacological inhibition of this process.
FIG. 2. Effect of tunicamycin on transduction efficiency of BAGEVHence, other potential mechanisms were sought (results
vector on rat fibroblast lines 3Y1 (l) and 3Yzrv1 (s), on primary culturesare summarized in Table 3). First, we determined whether
of rat mammary fibroblasts (m), and on a line of rat dermal fibroblaststhe poor susceptibility of primary cultures of rat (RMF)
(RDFplt1) immortalized by PyLT (n). For further details, see Methods
fibroblasts involved the presence of inhibitory factors se- and Table 2.
creted by these cells. However, conditioned medium from
RMF did not modify transduction of the highly susceptible
3Y1 cells. Second, since previous studies have shown in enhanced transduction efficiency, we examined the
that in vitro treatment of human immunodeficiency virus effect of dNTPs on cellular entry of MuLV vector. However,
type 1 (Zhang et al., 1993) and of MuLV vector (Zhang et exposing the BAGEV vector to 0–5 mM dNTPs prior to
al., 1995) with dNTPs, to initiate reverse transcription being added to the cells resulted in no change in trans-
within the virion (Lori et al., 1992; Trono, 1992), resulted duction efficiency, regardless of whether the cells were
highly permissive for, or refractory to, vector penetration.
Third, we studied the potential role of protease inhibitors.
Because tumorigenic transformation was in general asso-
ciated with a decrease in MuLV vector entry, we reasoned
that enhanced protease production, which is a known
property of transformed cells (Mignatti and Rifkin, 1993),
could in part be responsible for cleavage of MuLV recep-
tor and thus for impaired vector entry. However, treatment
of immortalized and neoplastically transformed cells with
SBTI, aprotinin, or leupeptin failed to significantly modify
transduction by the ecotropic vector. Finally, to ascertain
that promoter inactivation (Cepko, 1989) and(or) LacZ
gene deletion (McLachlin et al., 1993) were not responsi-
ble for the apparently poor transduction of certain cell
types, we measured the number of G418-resistant colo-
nies [in the BAG DNA the b-galactosidase gene is driven
FIG. 1. Role of cellular aging in transduction efficiency of BAGEV by the LTR and the Neor gene by the SV40 early promoter
vector on primary cultures of rat mammary fibroblasts (RMF) and mam- (Price et al., 1987)] in representative transduction experi-mary epithelial cells (RMEC). Primary cells were transduced as de-
ments with normal, immortalized, and transformed cells.scribed under Methods after various times of continuous growth in
culture. As reported in detail elsewhere (Tavoloni, 1997), however,
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TABLE 2
Effect of Glycosylation Inhibitors on Mammalian Cell Transduction by the BAGEV Vector
Cell type Control Tunicamycin 1-Deoxymannojirimycin Swansonine
Rat cells
3Y1 43,786 { 3870 131,428 { 23540 45,859 { 4212 63,915 { 9216
3Yzrv1 1,842 { 238 21,024 { 5018 ND ND
RMF 51.3 { 11.0 8,487 { 1180 1,818 { 356 2,285 { 194
RMF 41.7 { 10.3 48.5 { 9.4a 52.6 { 13.1a 36 { 8a
RMFztv1 1,507 { 288 41,342 { 7617 ND ND
RMFzsv1 138 { 31 7,916 { 1235 ND 1,844 { 306
RMFplt1 361 { 16.2 13,474 { 2081 4,638 { 726 ND
RDFzev1 175 { 27 5,920 { 786 ND ND
RDFplt1 61.5 { 16.2 13,508 { 2321 ND ND
Human cells
184B5 0 0 0 0
T47D 0 0 ND ND
Note. Data are means { SD of three to six determinations and indicate numbers of X-Gal-positive cells/dish. For definitions of cell types see
Methods and Table 1. Cells were exposed to glycosylation inhibitors for 24 hr prior to being transduced. Optimal concentrations of the drugs were
determined in dose–response experiments (see Fig. 2). Data shown were obtained with the following concentrations. Tunicamycin: 50 ng/ml in
3Y1 cells and derived transformed line (3Yzrv1); 500 ng/ml in rodent primary fibroblasts (RMF and RDF) and immortalized and transformed lines;
and 50–500 ng/ml in the 184B5 and T-47D human mammary lines. 1-Deoxymannojirimycin and swansonine were added at 200 and 20 mg/ml,
respectively, to all cell types studied. ND, not determined.
a Cells were treated with 500 ng/ml tunicamycin, 200 mg/ml 1-deoxymannojirimycin, or 20 mg/ml swansonine for 30 min prior to being exposed
to the virus.
the number of G418-resistant colonies paralleled that of to gain information on MuLV cellular tropism. Although
a number of studies have examined the ability of MuLVX-Gal-positive cells and the G418/X-Gal ratio invariably
ranged from 1.2 to 1.4, regardless of whether the infected vectors to transduce mammalian cells, no systematic
study comparing cells in primary culture to cells withcells were highly or poorly permissive for MuLV vector
entry (data not shown). altered growth properties has to our knowledge been
published. Under optimal conditions for in vitro cellular
DISCUSSION transduction, we found striking differences in MuLV vec-
tor transduction efficiency among various cell types. Pri-In the present studies, we wished to transduce various
mary cultures of rat fibroblasts, particularly those derivedcell types with a recombinant MuLV vector in the attempt
from mature animals, were highly resistant to entry of the
ecotropic virus, when compared to immortalized lines.
TABLE 3
Nonestablished rat mammary epithelial cells were also
Effect of Various Treatments on BAGEV Transduction poorly transduced, yet the difference was less pro-
of Rodent Cells nounced when compared to rodent mammary lines.
These differences were not related to technical artifactsTreatment 3Y1 RMF RMFzsv1
in that exploring different infectivity procedures (e.g.,
None 43,540 53 125 changing polybrene concentration, pH of culture me-
Conditioned medium 44,860 — — dium, density of target cells, and time of exposure to the
Leupeptin — — 182 virus) failed to improve significantly the transduction of
Aprotinin — — 174
poorly permissive cells. Thus, the different susceptibilit-SBTI 40,185 — 153
ies to MuLV vector entry must reflect intrinsic propertiesdNTPs 41,028 45 —
of the cells under study.
Note. Data are means of two determinations and represent numbers To clarify the significance of these differences, we pur-
of X-Gal-positive cells/dish. Cells were treated as indicated prior to sued a number of strategies. The results reported here
BAGEV transduction. For definitions of cell types, see Methods and
indicate that the variability in transduction efficiency isTables 1 and 2. Conditioned medium from primary cultures of rat mam-
not related to differences in cellular growth rate nor tomary fibroblasts (RMF), which were poorly susceptible, was tested on
entry of ecotropic vector into 3Y1 cells, since these cells were highly the induction of the immortal or transformed phenotype.
permissive for BAGEV entry. Cells were treated with leupeptin, aproti- Both cellular immortalization and tumorigenic transfor-
nin, and soybean trypsin inhibitor (SBTI) at 50 mg/ml, 200 kallikrein
mation facilitated entry of MuLV vector entry, when com-units/ml, and 100 mg/ml, respectively, as described under Methods.
pared to the corresponding primary cells. However, theMuLV ecotropic vector was treated with dNTPs (5 mM) in the presence
of MgCl2 (2.5 mM) at 377 for 2 hr prior to being added to cultures. effect of these altered growth conditions was not consis-
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tent, did not account for the difference between primary LacZ gene deletion. Also, in contrast to previous studies
on cellular entry of human immunodeficiency virus typecells and the immortalized 3Y1 line, and was minimal
in some cell types. Thus, it is clear that the improved 1 (Zhang et al., 1993) and of amphotropic MuLV vector
(Zhang et al., 1995), in vitro treatment of the ecotropictransduction of primary cells following oncogene immor-
talization or transformation is secondary in part to the vector with dNTPS, to jump-start reverse transcription
prior to virus entry, failed to improve transduction offaster growth rate of the immortalized and/or transformed
cells and, primarily, to an indirect effect due to the altered poorly permissive cells. Thus, it seems likely that the
differences in transduction efficiency not eliminated bybiochemistry of these cells.
On the other hand, the present results provide convinc- tunicamycin treatment reflect a variable effect of this drug
on protein glycosylation and/or differences in MuLV re-ing evidence that N-linked cellular glycosylation plays a
pivotal role in determining cellular susceptibility to MuLV ceptor expression level.
The importance of the present findings is threefold.vector entry. Inhibition of such a process with swanson-
ine, 1-deoxymannojirimycin, and, primarily, tunicamycin First, the wide variability in MuLV vector transduction
efficiency indicates that cellular entry of MuLV is highlyincreased entry of ecotropic MuLV vector into all rodent
cells studied. In the more resistant cells, transduction selective. A better understanding of MuLV cellular trop-
ism is essential not only to clarify virus biology, but alsoefficiency increased by up to 200-fold or more. The pre-
cise mechanism by which inhibition of glycoprotein for- to design efficient gene delivery protocols with this vec-
tor. Second, the major increase in transduction efficiencymation results in enhanced cellular entry of the ecotropic
vector cannot be established from the present findings. induced by inhibitors of cellular glycosylation under-
scores the usefulness of these drugs to boost deliveryHowever, our results are consistent with the hypothesis
that hypoglycosylation of the ecotropic MuLV receptor, of genetic material with the ecotropic vector into poorly
permissive cells such as rodent primary fibroblasts. Fi-MCAT-1 (Albritton et al., 1989), is responsible for this
effect. The increase in transduction efficiency induced nally, the finding that cellular entry of MuLV is augmented
by tunicamycin treatment indicates that glycosylation ofby inhibitors of glycosylation was not due to nonspecific
effects of these drugs and was not observed in human cellular proteins, presumably of the MCAT-1 receptor, is
a major determinant of cellular defense against MuLVcells which are not permissive for entry of the ecotropic
vector. More importantly, it has been reported that, in entry. Since penetration of other viruses is also modu-
lated by protein glycosylation, unraveling this mechanismXenopus oocytes, MCAT-1 is glycosylated and that bind-
ing of the ecotropic gp70 to such a transporter disrupts in greater detail may shed new light on the pathway of
virus entry into cells and ultimately lead to the develop-the glycosylation process (Kim and Cunningham, 1993).
In addition, a more recent study by Wang et al. (1996) has ment of pharmacologic strategies for inhibiting this pro-
cess.demonstrated that cells expressing glycosylated MCAT-1
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